|
Bone Mineral Density in Women with Major Depression Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Bone Mineral Density in Women with Major Depression conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Bone Mineral Density in Women with Major Depression Clinical research trials and Bone Mineral Density in Women with Major Depression healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Bone Mineral Density in Women with Major Depression. Bone Mineral Density in Women with Major Depression Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Bone Mineral Density in Women with Major Depression clinical trial. Human subjects often receive the most effective healthcare possible for their Bone Mineral Density in Women with Major Depression condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "B" Clinical Trials Conditions > Bone Mineral Density in Women with Major Depression  Bone Mineral Density in Women with Major Depression
Bone Mineral Density in Women with Major Depression
For Condition: Healthy,Involutional Depression,Osteoporosis
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this study is to examine calcium absorption and bone mineral density in women with depression. Research indicates that pre-menopausal women with depression have significantly lower bone mineral density (BMD) than pre-menopausal women without depression. Although the mechanisms of BMD loss are unclear, researchers believe that individuals with depression have impaired calcium absorption. However, it is unknown whether the abnormal absorption is a result of depression or a side effect of the drugs used to treat it. This study will compare calcium absorption in women with depression and in healthy women without depression. Participants in this study will be given two non-radioactive calcium isotopes. One can be taken by mouth and the other must be injected. Participants will have the level of isotopes in their urine measured to estimate true fractional calcium absorption (TFCA). Participants may also have a dual X-ray absorptiometry (DEXA) scan to measure total body adiposity and lean body mass.
Details: We demonstrated a marked decrease in bone mineral density in 24 otherwise healthy pre-menopausal women, as compared with 24 healthy closely matched controls. The decrease was significant at several trabecular bone sites (e.g. 13.6% at the femoral neck, 13.6% at the Ward's triangle, and 10.8% at the trochanter). Epidemiological studies indicate that losses in trabecular bone mineral density of these magnitudes are associated with an increased lifetime risk for fracture of up to 50%. Although the mechanism(s) of the loss in bone mineral density in our patients with past or current depression has not yet been elucidated, these subjects showed significantly higher 24 hour urinary free cortisol excretion than their matched controls. These data are being upheld by our ongoing studies. It is important for the Intramural Program to screen large numbers of depressed patients to highlight this problem for practitioners. It is also essential for us to measure bone mineral density and to have these measures as a basis for correlation with biological variables. In addition, we cannot assume that the pathophysiological mechanisms is hypercortisolism alone. Indeed the pattern we have seen via bone biopsy and histomorphometry differs for classic glucocorticoid bone loss. In addition, the clinical presentation, with a preponderant loss of bone mineral density, is different from that with glucocorticoid excess alone. With glucocorticoids the main loss is at the level of the spine. Our continuation of the longitudinal NIMH study of mothers with and without mood disorders and their offspring, provides us with a unique opportunity to assess clinical and behavioral variables early in life or adulthood that influence the rate of bone loss. We follow almost 300 patients in this study. Many will have DEXA's. This will tell us whether childhood depression leads to loss of bone mineral density in early adulthood. More recently, the IRB approved the increase in the accrual ceiling to include subjects being studied under protocol 00-M-0049, a study of insulin resistance in subjects with major depression utilizing the hyperinsulinemic-euglycemic glucose clamp. This later group will provide information regarding metabolic correlates to insulin resistance, body fat content, and bone mineral density. The dual X-ray absorptiometry measure also provides an accurate estimate of total body adiposity and lean body mass. We have found that depressed women have a significant decrease in lean body mass that correlates with their loss of bone mineral density. Depressed women also have significant increases in total body adiposity. Thus, this protocol is also relevant to our evaluating common factors in the premature coronary artery disease and premature osteoporosis of depression.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: A history of current or past major depression of at least four months duration, or a history of two or more brief depressive episodes will be the primary criteria for inclusion. No specific inclusion criteria are set for normal volunteers. EXCLUSION CRITERIA: DEPRESSED SUBJECTS: Pregnant women will not be eligible to participate. Known medical causes of osteoporosis, other than depression. Current or past history of eating disorders, or schizophrenia, as per DSM-IV. Chronic use of steroids. NORMAL CONTROLS: Pregnant women will not be eligible to participate. Known medical causes of osteoporosis. Any history or current DSM-IV diagnosis, including depression, eating disorders, alcohol or drug abuse. History or current evidence of any significant clinical or laboratory abnormalities.
Total Enrollment: 585
Location and Contact Information:
National Institute of Mental Health (NIMH) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Philip Gold 3014961945
Additional Information:
Study ID Numbers: 940121; 94-M-0121
Study Start Date: April 6, 1994
Record last reviewed: April 24, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001413
Other Osteoporosis Studies:
1. Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease
2. Experimental Ebola Vaccine Trial
3. Perimenopause-Related Mood and Behavioral Disorders
4. Reward-Related Processes and Brain Function
5. Study of Norepinephrine Levels and Sympathetic Nervous System Activity
Related Studies:
Other Osteoporosis Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Bone Mineral Density in Women with Major Depression
|
|
|
|
|
|
|
|
